Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVS CVS Health	$67.88 +0.2%	$62.72	$43.56 ▼ $75.27	$85.59B	0.54	11.59 million shs	8.64 million shs
PETS PetMed Express	$4.05 -3.3%	$4.44	$2.90 ▼ $6.85	$83.66M	0.78	308,498 shs	286,551 shs
WBA Walgreens Boots Alliance	$11.16 -0.1%	$10.80	$8.08 ▼ $19.62	$9.64B	0.62	20.87 million shs	10.68 million shs
YI 111	$8.58 +5.8%	$7.92	$4.15 ▼ $14.10	$73.38M	0.46	22,176 shs	13,853 shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVS CVS Health	+0.14%	+2.02%	+3.08%	+51.22%	-14.68%
PETS PetMed Express	-3.34%	-0.98%	-8.37%	-15.98%	-13.46%
WBA Walgreens Boots Alliance	-0.09%	+0.36%	+4.45%	+19.61%	-42.89%
YI 111	+5.80%	-14.88%	-3.27%	+37.72%	-30.24%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CVS CVS Health	4.9055 of 5 stars	2.5	4.0	3.3	3.9	2.9	3.3	3.1
PETS PetMed Express	0.6035 of 5 stars	0.8	2.0	0.0	0.0	3.0	1.7	0.6
WBA Walgreens Boots Alliance	3.5587 of 5 stars	1.9	4.0	2.5	2.3	2.4	1.7	0.6
YI 111	0.5492 of 5 stars	0.0	3.0	0.0	0.0	2.2	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVS CVS Health	2.90	Moderate Buy	$70.41	3.73% Upside
PETS PetMed Express	1.50	Reduce	$3.50	-13.58% Downside
WBA Walgreens Boots Alliance	1.83	Reduce	$10.59	-5.10% Downside
YI 111	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest CVS, WBA, YI, and PETS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/22/2025	YI 111	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (D-)
3/21/2025	CVS CVS Health	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$72.00 ➝ $74.00
3/7/2025	YI 111	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E+)
2/28/2025	WBA Walgreens Boots Alliance	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Sell	$11.00 ➝ $9.00
2/24/2025	WBA Walgreens Boots Alliance	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
2/19/2025	YI 111	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E+)
2/18/2025	CVS CVS Health	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$77.00
2/18/2025	CVS CVS Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$80.00 ➝ $81.00
2/13/2025	CVS CVS Health	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$68.00 ➝ $73.00
2/13/2025	CVS CVS Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$60.00 ➝ $76.00
2/13/2025	CVS CVS Health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$71.00 ➝ $73.00

(Data available from 4/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVS CVS Health	$372.81B	0.23	$9.48 per share	7.16	$60.06 per share	1.13
PETS PetMed Express	$247.01M	0.34	$0.02 per share	193.50	$4.66 per share	0.87
WBA Walgreens Boots Alliance	$150.41B	0.06	$6.10 per share	1.83	$13.91 per share	0.80
YI 111	$14.40B	0.01	N/A	N/A	($9.79) per share	-0.88

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVS CVS Health	$4.61B	$3.66	18.55	10.03	0.98	1.24%	9.11%	2.71%	4/29/2025 (Estimated)
PETS PetMed Express	-$7.46M	$0.01	405.41	135.00	N/A	0.14%	0.37%	0.23%	4/21/2025 (Estimated)
WBA Walgreens Boots Alliance	-$8.64B	-$10.24	N/A	7.64	1.31	-5.87%	17.61%	2.89%	4/3/2025 (Estimated)
YI 111	-$43.07M	-$0.64	N/A	∞	N/A	-1.75%	N/A	-8.67%	5/21/2025 (Estimated)

Latest CVS, WBA, YI, and PETS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/3/2025	N/A	WBA Walgreens Boots Alliance	$0.53	N/A	N/A	N/A	$37.90 billion	N/A
3/20/2025	Q4 2024	YI 111	N/A	-$0.04	N/A	-$0.04	N/A	$527.14 million
2/12/2025	Q4 2024	CVS CVS Health	$0.89	$1.19	+$0.30	$1.30	$96.90 billion	N/A
2/10/2025	Q3 25	PETS PetMed Express	-$0.01	-$0.03	-$0.02	-$0.03	$60.00 million	N/A
1/10/2025	Q1 25	WBA Walgreens Boots Alliance	$0.38	$0.51	+$0.13	-$0.31	$37.40 billion	$39.50 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVS CVS Health	$2.66	3.92%	+9.97%	72.68%	N/A
PETS PetMed Express	$0.90	22.22%	N/A	9,000.00%	N/A
WBA Walgreens Boots Alliance	$1.00	8.96%	-19.12%	N/A	N/A
YI 111	N/A	N/A	N/A	N/A	N/A

Latest CVS, WBA, YI, and PETS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/20/2025	CVS CVS Health	quarterly	$0.6650	3.89%	4/22/2025	4/22/2025	5/1/2025
1/3/2025	CVS CVS Health	quarterly	$0.6650	6.02%	1/23/2025	1/23/2025	2/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVS CVS Health	0.80	0.81	0.60
PETS PetMed Express	N/A	1.43	1.18
WBA Walgreens Boots Alliance	0.68	0.64	0.30
YI 111	N/A	1.09	0.51

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVS CVS Health	80.66%
PETS PetMed Express	73.33%
WBA Walgreens Boots Alliance	58.59%
YI 111	21.32%

Insider Ownership

Company	Insider Ownership
CVS CVS Health	0.24%
PETS PetMed Express	1.10%
WBA Walgreens Boots Alliance	17.50%
YI 111	43.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVS CVS Health	300,000	1.26 billion	1.26 billion	Optionable
PETS PetMed Express	210	20.66 million	20.43 million	Optionable
WBA Walgreens Boots Alliance	325,000	864.15 million	712.93 million	Optionable
YI 111	1,520	8.55 million	4.80 million	Optionable

CVS, WBA, YI, and PETS Headlines

Recent News About These Companies

111, Inc. (NASDAQ:YI) Short Interest Up 94.1% in March

March 29, 2025 | americanbankingnews.com

Short Interest in 111, Inc. (NASDAQ:YI) Expands By 94.1%

March 28, 2025 | marketbeat.com

111 (NASDAQ:YI) Earns "Sell (D-)" Rating from Weiss Ratings

March 24, 2025 | americanbankingnews.com

Weiss Ratings Reiterates Sell (D-) Rating for 111 (NASDAQ:YI)

March 24, 2025 | marketbeat.com

111, Inc. (NASDAQ:YI) Q4 2024 Earnings Call Transcript

March 22, 2025 | msn.com

111, Inc. Reports First Operational Profit Amid Challenges

March 21, 2025 | tipranks.com

111 (NASDAQ:YI) Announces Quarterly Earnings Results

March 21, 2025 | marketbeat.com

111, Inc. (YI) Q4 2024 Earnings Call Transcript

March 21, 2025 | seekingalpha.com

111, Inc. Achieves First-Ever Annual Operating Profit in 2024

March 20, 2025 | tipranks.com

111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results

March 20, 2025 | prnewswire.com

111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025

March 12, 2025 | prnewswire.com

111 (NASDAQ:YI) Receives Sell (E+) Rating from Weiss Ratings

March 8, 2025 | marketbeat.com

111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow

February 20, 2025 | prnewswire.com

(YI) Investment Analysis and Advice

February 13, 2025 | news.stocktradersdaily.com

111, Inc. meets NASDAQ's listing standards again

February 11, 2025 | msn.com

111 Inc regains Nasdaq compliance with share price

February 11, 2025 | msn.com

111, Inc. Regains NASDAQ Compliance

February 11, 2025 | tipranks.com

111, Inc. Regains Compliance with NASDAQ Requirement

February 11, 2025 | prnewswire.com

Trading (YI) With Integrated Risk Controls

February 2, 2025 | news.stocktradersdaily.com

111 Inc ADR trading halted, news pending

January 24, 2025 | markets.businessinsider.com

Compound Semiconductor Market to surpass USD 111.6 billion by 2032, Says Global Market Insights inc.

January 22, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NVIDIA Insiders Sell: This Is What It Means for the Market
By Thomas Hughes | March 25, 2025
View NVIDIA Insiders Sell: This Is What It Means for the Market
Joby Aviation: From Prototype to Profitability
By Jeffrey Neal Johnson | March 11, 2025
View Joby Aviation: From Prototype to Profitability
Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
By Ryan Hasson | March 25, 2025
View Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
3 Dividend Stocks Offering Higher Yields and Bullish Forecasts
By Sarah Horvath | March 17, 2025
View 3 Dividend Stocks Offering Higher Yields and Bullish Forecasts
4 Healthcare Stocks With Massive Gains—and More to Come
By Sarah Horvath | March 29, 2025
View 4 Healthcare Stocks With Massive Gains—and More to Come

CVS, WBA, YI, and PETS Company Descriptions

CVS Health NYSE:CVS

$67.88 +0.13 (+0.19%)

Closing price 04/1/2025 03:59 PM Eastern

Extended Trading

$68.10 +0.22 (+0.32%)

As of 04/1/2025 07:59 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

PetMed Express NASDAQ:PETS

$4.05 -0.14 (-3.34%)

Closing price 04/1/2025 04:00 PM Eastern

Extended Trading

$4.06 +0.00 (+0.12%)

As of 04/1/2025 06:48 PM Eastern

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Walgreens Boots Alliance NASDAQ:WBA

$11.16 -0.01 (-0.09%)

Closing price 04/1/2025 04:00 PM Eastern

Extended Trading

$11.14 -0.02 (-0.18%)

As of 04/1/2025 07:52 PM Eastern

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

111 NASDAQ:YI

$8.58 +0.47 (+5.80%)

Closing price 04/1/2025 03:59 PM Eastern

Extended Trading

$8.70 +0.12 (+1.34%)

As of 04/1/2025 04:08 PM Eastern

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time